Search
Neurosense Therapeutics Ltd
NRSNAdd to Watchlist
2.460USD
+0.020+0.82%
Close 10-23 16:00（ET）
4.67MMarket Cap
LossP/E TTM
Neurosense Therapeutics Ltd (NRSN) Stock Price Target & Forecast
Analyst Rating
Based on 3 analysts giving stock ratings to Neurosense Therapeutics Ltd in the past month.
Buy
0 Strong Buy
2 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
96.375USD+3039.25%
NRSN Analyst Recommendation Trends
In the current month, NRSN has received 2 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. NRSN average Analyst price target in the last month is 96.375.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
0
0
0
0
0
0
0
0
2
3
3
3
3
4
4
3
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
3
3
3
3
4
4
3
Financial Forecasting
Based on analysts' estimates, NRSN EPS is projected to reach 0.000 in FY2026Q1, following reported EPS of -0.437 in FY2025Q4. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-2.07
--
-3.20
--
-3.60
Actual
-0.44
--
--
--
--
Surprise
+78.87%
--
--
--
--
FAQs
What is Neurosense Therapeutics Ltd's price target?
Analysts forecast that Neurosense Therapeutics Ltd's price target is USD 14.00, with the highest forecast at USD 14.00 and the lowest forecast at USD 14.00.
What is the analyst rating for Neurosense Therapeutics Ltd?
Based on the ratings of Neurosense Therapeutics Ltd's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.